In 2020, the omics systems section accounted for the biggest share of the market. Increase use of cancer biomarkers For brand spanking new developments is driving the growth of the segment.The accomplishment of immunotherapies in managing several cancers has brought about a surge in investigation and improvement of immuno-oncology biomarkers. These